The authors have identified a panel of markers in flow cytometry (FCM) that can help diagnose acute promyelocytic leukemia (APL) with great accuracy. We hereby share a similar experience.
Hemoglobin ranged from 5.7 to 13 g/dL, with a total leukocyte count of 1.4 to 85.1 × 10 3 /mL. Fifteen patients (93%) displayed characteristic hypergranular morphology (typical variant), and 1 patient (7%) showed microgranular morphology. However, faggot cells were observed in only 7 (44%) cases. Immunophenotyping revealed that all patients had abnormal cells with intermediate to high side scatter and dim CD45 expression. HLA-DR was negative in 15 patients (93%). One patient showed dim expression of HLA-DR (7%). All 16 patients (100%) were negative for CD34, CD14, and CD11b. One patient with a hypogranular variant was negative for HLA-DR and CD34 but showed an aberrant expression of CD4.
It appears, therefore, that the combined negative expression of HLA-DR, CD34, CD11b, and CD14 in the background of myeloid-specific antigens provides a rapid diagnosis of APL by FCM in almost all cases. Additional use of CD11c would have further added value to this conclusion.
